[ET Net News Agency, 5 September 2025] 3SBIO (01530) rose 9.7% to HK$33.1.
It hits an intra-day high of HK$33.2, breaking above the 20-D SMA of HK$30.764, and an intra-day low of HK$30.5. The total shares traded was 39.01 million, with a value of HK$1.25b. The active buy/sell ratio is 65:35, with net buying turnover of HK$361.46m. J.P. MORGAN BRO (HK) accounts for greatest net responsive buying turnover of HK$30.91m, with volume weighted average price of HK$31.986. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$100.79m, with volume weighted average price of HK$32.024.
Basic Information| Nominal | 33.100 | % Chg | +9.75% |
| High | 33.200 | Low | 30.500 |
| Shares Tr | 39.01m | Turnover | 1.25b |
| 10-D SMA | 30.120 | %H.V | 52.726 |
| 20-D SMA | 30.764 | VWAP | 31.977 |
| 50-D SMA | 29.245 | RSI14 | 59.762 |
Status: Breaking above the 20-D SMA, active buy/sell ratio is 65:35, with net buying turnover of HK$361.46m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| 3SBIO (01530) | 33.10 | +9.75 |
| SINO BIOPHARM (01177) | 8.88 | +5.84 |
| EVEREST MED (01952) | 61.05 | +3.21 |
| KEYMED BIO-B (02162) | 73.50 | +7.30 |
| WUXI XDC (02268) | 65.45 | +3.64 |
| ASCENTAGE-B (06855) | 78.45 | +4.53 |
| ZAI LAB (09688) | 23.98 | +4.08 |
| AKESO (09926) | 153.70 | +4.42 |
| INNOCARE (09969) | 17.58 | +0.86 |
| REMEGEN (09995) | 91.20 | +0.83 |
(ed)
